Metastases and multiple myeloma generate distinct transcriptional footprints in osteocytes in vivo

Journal of Pathology

Volumn 214, Issue 5, 2008, Pages 617-626

  Eisenberger, S ^a   Ackermann, K ^a   Voggenreiter, G ^b   Sultmann H ^a   Kasperk, C ^c   Pyerin, W ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bone metastasis; CUP syndrome; Microdissection; Multiple myeloma; Osteocytes; TGF ; Transcript profiling

Indexed keywords

TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BONE DISEASE; BONE METASTASIS; CELL STRUCTURE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; OSTEOCYTE; PRIORITY JOURNAL; PUNCH BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSCRIPTION INITIATION; UNINDEXED SEQUENCE; UPREGULATION;

AGED; BONE NEOPLASMS; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRODISSECTION; MIDDLE AGED; MULTIPLE MYELOMA; OSTEOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 41649087543     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2322     Document Type: Article

References (30)

1. Knothe Tate ML. 'Whither flows the fluid in bone?' An osteocyte's perspective. J Biomech 2003;36:1409-1424.
2. Knothe Tate ML, Adamson JR, Tami AE, Bauer TW. The osteocyte. Int J Biochem Cell Biol 2004;36:1-8.
3. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-593.
4. Siclari VA, Guise TA, Chirgwin JM. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metast Rev 2006;25:621-633.
5. Zhao S, Kato Y, Zhang Y, Harris S, Ahuja SS, Bonewald LF. MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res 2002;17:2068-2079.
6. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 2003;22:6267-6276.
7. Heino TJ, Hentunen TA, Väänänen HK. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal cells and their differentiation into osteoblasts. Exp Cell Res 2004;294:3633-3638.
8. Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Löwik CW, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 2005;19:1842- 1860.
9. Kurata K, Heino TJ, Higaki H, Väänänen HK. Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture. J Bone Miner Res 2006;21:616-625.
10. Hedgecock NL, Hadi T, Chen AA, Curtiss SB, Martin RB, Hazelwood SJ. Quantitative regional associations between remodeling, modeling, and osteocyte apoptosis and density in rabbit tibial mid-shafts. Bone 2007;40:627-637.
11. Wittrant Y, Théoleyre S, Chipoy C, Padrines M, Blanchard F, Heymann D, et al. RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta 2004;1704:49-57.
12. Blair JM, Zhou H, Seibel MJ, Dunstan CR. Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol 2006;3:41-49.
13. Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2002;2:175-187.
14. Epstein J, Walker R. Myeloma and bone disease: 'the dangerous tango'. Clin Adv Hematol Oncol 2006;4:300-306.
15. Van de Wouw AJ, Jansen RLH, Sped EJM, Hillen HFP. The unknown biology of the unknown primary tumour: a literature review. Ann Oncol 2003;14:191-196.
16. Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 2005;54:243-250.
17. Eisenberger S, Hoppe G, Pyerin W, Ackermann K. High quality RNA preparation for transcript profiling of osteocytes from native human bone microdissections. Anal Biochem 2004;335:260-266.
18. Reno C, Marchuk L, Sciore P, Frank CB, Hart DA. Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. Biotechniques 1996;22:1082-1086.
19. Knerr K, Ackermann K, Neidhart T, Pyerin W. Bone metastasis: osteoblasts affect growth and adhesion regulons in prostate tumour cells and provoke osteomimicry. Int J Cancer 2004;111:152-159.
20. Edlund S, Landström M, Heldin C-H, Aspenström P Transforming growth factor-β-induced mobilisation of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 2002;13:902-914.
21. Yang J-J. Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest. Biochem Biophys Res Commun 2002;297:105-110.
22. Miki H, Takenawa T. Regulation of actin dynamics by WASP family proteins. J Biochem 2003;134:309-313.
23. Edlund S, Landström M, Heldin C-H, Aspenström P. Smad7 is required for TGFβ-induced activation of the small GTPase Cdc42. J Cell Sci 2004;117:1835-1846.
24. Huang C-Y, Chueh PJ, Tseng C-T, Liu K-Y, Tsai H-Y, Kuo W-W, et al. ZAK re-programs atrial natriuretic factor expression and induces hypertrophic growth in H9c2 cardiomyoblast cells. Biochem Biophys Res Commun 2004;324:973-980.
25. Huang C-Y, Kuo W-W, Chueh P-J, Tseng C-T, Chou M-Y, Yang J-J. Transforming growth factor-β induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK. Biochem Biophys Res Commun 2004;324:424-431.
26. ten Dijke P, Hill CS. New insights into TGFβ-Smad signalling. Trends Biochem Sci 2004;29:265-273.
27. Moustakas A, Heldin CH. Non-Smad TGFβ signals. J Cell Sci 2005;118:3573-3584.
28. Datta PK, Moses HL. STRAP and Smad7 synergize in the inhibition of transforming growth factor-β signaling. Mol Cell Biol 2000;20:3157-3167.
29. Verrecchia F, Chu M-L, Mauviel A. Identification of novel TGFβ/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001;276:17058-17062.
30. Zavadil J, Bitzer M, Liang D, Yang Y-C, Massimi A, Kneitz S, et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc Natl Acad Sci USA 2001;98:6686-6691.